[Complications and management of hematopoietic malignancy therapy].
Horiuchi A·[Rinsho ketsueki] The Japanese journal of clinical hematology
Infection and refractoriness to platelet transfusion, as complications in hematopoietic malignancy therapy, were investigated. The Hanshin Study Group of Hematopoietic Disorders and Infection treated with 3,346 cases of bacterial infection (7.8% sepsis, 71% sepsis suspected, 13.7% respiratory infection) during the past…